COUGH SUPPRESSANT

COUGH SUPPRESSANT was reported 1048 times

COUGH SUPPRESSANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URTICARIA THERMAL 20 0.1408
1 HERNIA DIAPHRAGMATIC REPAIR 1 0.0909
2 NAIL BED TENDERNESS 8 0.0702
3 ADMINISTRATION SITE ERYTHEMA 14 0.0491
4 COLONIC HAEMATOMA 3 0.0353
5 EPITHELIOID MESOTHELIOMA 9 0.0256
6 BIPHASIC MESOTHELIOMA 1 0.0233
7 DRESSLER'S SYNDROME 1 0.0227
8 CYCLIC NEUTROPENIA 1 0.0192
9 CHEMICAL INJURY 13 0.0159
10 PERITONEAL MESOTHELIOMA MALIGNANT 3 0.0155
11 NASAL FLARING 2 0.0148
12 CARDIOACTIVE DRUG LEVEL DECREASED 2 0.0117
13 PROCEDURAL HYPERTENSION 2 0.0106
14 PLEURAL MESOTHELIOMA MALIGNANT 3 0.0097
15 ANAL POLYP 1 0.0097
16 LICE INFESTATION 2 0.0095
17 ANAL EROSION 1 0.0091
18 OVERLAP SYNDROME 6 0.0086
19 DERMATOPHYTOSIS OF NAIL 1 0.0084
20 ABDOMINAL WALL CYST 1 0.0082
21 IMMOBILISATION PROLONGED 1 0.0082
22 AUTONOMIC NEUROPATHY 8 0.0079
23 DENTURE WEARER 2 0.0077
24 C-REACTIVE PROTEIN 7 0.0076
25 ORTHOSIS USER 2 0.0071
26 OCCUPATIONAL EXPOSURE TO TOXIC AGENT 2 0.0070
27 BURNS FIRST DEGREE 2 0.0070
28 ELECTROCARDIOGRAM QT INTERVAL 1 0.0069
29 HEPATIC ENZYME 1 0.0067
30 LUPUS VULGARIS 8 0.0063
31 BACTERIAL TRANSLOCATION 2 0.0063
32 EYELID BLEEDING 1 0.0058
33 CHRONIC RESPIRATORY DISEASE 2 0.0057
34 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
35 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 1 0.0056
36 APPLICATION SITE HAEMATOMA 1 0.0055
37 ACCELERATED HYPERTENSION 2 0.0053
38 HEPATIC VASCULAR THROMBOSIS 1 0.0052
39 ANTICHOLINERGIC SYNDROME 8 0.0050
40 REPRODUCTIVE TRACT DISORDER 2 0.0050
41 VITAMIN B12 DEFICIENCY 20 0.0049
42 GREATER TROCHANTERIC PAIN SYNDROME 1 0.0049
43 BURNS THIRD DEGREE 5 0.0047
44 ADULT FAILURE TO THRIVE 1 0.0047
45 BONE SCAN ABNORMAL 2 0.0047
46 HYPERCHOLESTEROLAEMIA 44 0.0046
47 DEEP VEIN THROMBOSIS POSTOPERATIVE 9 0.0045
48 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 3 0.0045
49 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
50 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
51 METAPLASIA 2 0.0042
52 DRAINAGE 2 0.0041
53 HYPERPARATHYROIDISM SECONDARY 10 0.0040
54 EXPOSURE TO CHEMICAL POLLUTION 6 0.0036
55 AGONAL RESPIRATION 1 0.0035
56 CARBUNCLE 1 0.0035
57 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
58 RETINITIS 6 0.0035
59 NASAL MUCOSAL DISORDER 2 0.0034
60 BURNS SECOND DEGREE 6 0.0034
61 ENTEROCOLITIS VIRAL 1 0.0033
62 VULVOVAGINAL SWELLING 6 0.0033
63 PIGMENTATION DISORDER 20 0.0032
64 HEPATIC ISCHAEMIA 1 0.0032
65 ADNEXAL TORSION 1 0.0032
66 BLOOD CHLORIDE DECREASED 8 0.0031
67 COLORECTAL ADENOMA 1 0.0031
68 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
69 JOINT DISLOCATION 31 0.0029
70 SWOLLEN JOINT COUNT INCREASED 9 0.0028
71 BLADDER TRANSITIONAL CELL CARCINOMA 4 0.0028
72 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
73 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
74 RHEUMATIC FEVER 12 0.0027
75 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 1 0.0027
76 MICROALBUMINURIA 2 0.0026
77 APPLICATION SITE BURN 13 0.0026
78 HYDROURETER 1 0.0026
79 NEPHROGENIC ANAEMIA 12 0.0026
80 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 2 0.0026
81 CONGENITAL DIAPHRAGMATIC HERNIA 1 0.0026
82 BRAIN COMPRESSION 1 0.0025
83 GENITAL ABSCESS 1 0.0025
84 HIGH RISK PREGNANCY 1 0.0025
85 DERMATITIS EXFOLIATIVE 12 0.0024
86 LABYRINTHITIS 6 0.0024
87 SKIN PLAQUE 20 0.0024
88 DIVORCED 1 0.0023
89 HOMELESS 1 0.0022
90 PRIMARY SEQUESTRUM 2 0.0022
91 BIOPSY BONE MARROW ABNORMAL 1 0.0022
92 CLONUS 6 0.0022
93 ALLERGY TO PLANTS 1 0.0022
94 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
95 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
96 ACTINOMYCOSIS 2 0.0021
97 COMA SCALE ABNORMAL 6 0.0021
98 DIZZINESS POSTURAL 20 0.0021
99 HELICOBACTER INFECTION 21 0.0020
100 SECRETION DISCHARGE 25 0.0020
101 HAEMANGIOMA OF LIVER 2 0.0020
102 BONE EROSION 7 0.0020
103 JOINT RANGE OF MOTION DECREASED 26 0.0019
104 BLOOD ALBUMIN ABNORMAL 1 0.0019
105 SCRATCH 20 0.0019
106 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
107 NEUROMYOPATHY 2 0.0019
108 HYPERTENSIVE NEPHROPATHY 2 0.0019
109 TRAUMATIC HAEMATOMA 2 0.0019
110 HIP ARTHROPLASTY 28 0.0018
111 PLEURITIC PAIN 5 0.0018
112 TEMPERATURE REGULATION DISORDER 4 0.0018
113 ENCEPHALOMALACIA 1 0.0018
114 BACTERIURIA 1 0.0018
115 SERONEGATIVE ARTHRITIS 2 0.0017
116 CHEMICAL BURN 2 0.0017
117 RHEUMATOID FACTOR POSITIVE 10 0.0017
118 THERMAL BURN 12 0.0017
119 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
120 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
121 IRRITABLE BOWEL SYNDROME 36 0.0017
122 HEPATORENAL FAILURE 1 0.0017
123 RECTAL CANCER 5 0.0016
124 DUODENAL ULCER PERFORATION 12 0.0016
125 HYPERCHLORAEMIA 1 0.0016
126 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
127 PERSONALITY DISORDER 4 0.0015
128 GINGIVAL DISCOMFORT 1 0.0015
129 ABSCESS ORAL 2 0.0015
130 MUSCLE INJURY 12 0.0014
131 AUTOIMMUNE DISORDER 14 0.0014
132 DERMATITIS DIAPER 1 0.0014
133 DEVICE ELECTRICAL FINDING 1 0.0014
134 EYE ROLLING 1 0.0014
135 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
136 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 10 0.0014
137 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
138 HYPOVOLAEMIA 8 0.0014
139 FIBROCYSTIC BREAST DISEASE 1 0.0014
140 ORAL MUCOSAL EXFOLIATION 2 0.0013
141 ERYTHEMA MULTIFORME 12 0.0013
142 INFECTION PARASITIC 1 0.0013
143 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
144 COSTOCHONDRITIS 2 0.0012
145 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
146 CHEMICAL BURN OF SKIN 3 0.0012
147 JOINT STIFFNESS 31 0.0012
148 SKIN WOUND 2 0.0012
149 CYSTOCELE 1 0.0012
150 FOOD REFUSAL 1 0.0011
151 KYPHOSIS 2 0.0011
152 BLOOD ALBUMIN INCREASED 1 0.0011
153 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
154 OROPHARYNGEAL DISCOMFORT 10 0.0011
155 INJECTION SITE DRYNESS 1 0.0011
156 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 7 0.0011
157 LIVE BIRTH 9 0.0011
158 BONE CYST 1 0.0011
159 SCIATICA 17 0.0011
160 MYELOPATHY 2 0.0011
161 HYPERTONIA 6 0.0010
162 IMPAIRED HEALING 34 0.0010
163 ULCER HAEMORRHAGE 7 0.0010
164 KNEE ARTHROPLASTY 21 0.0010
165 REBOUND ACID HYPERSECRETION 3 0.0010
166 LIP DRY 9 0.0010
167 HYPOCHROMIC ANAEMIA 1 0.0010
168 EXOSTOSIS 9 0.0010
169 FIBROSIS 3 0.0010
170 IMPULSE-CONTROL DISORDER 2 0.0010
171 DERMATITIS BULLOUS 7 0.0010
172 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
173 FOETAL DEATH 5 0.0010
174 FOLLICULITIS 10 0.0010
175 IRIDOCYCLITIS 3 0.0009
176 FIBROMYALGIA 23 0.0009
177 BONE DEMINERALISATION 1 0.0009
178 BLOOD SODIUM ABNORMAL 1 0.0009
179 CATHETER SITE ERYTHEMA 2 0.0009
180 PRESCRIBED OVERDOSE 18 0.0009
181 APPLICATION SITE VESICLES 6 0.0009
182 PERIODONTITIS 2 0.0009
183 FACET JOINT SYNDROME 3 0.0009
184 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
185 LIMB MASS 2 0.0009
186 DIABETIC NEPHROPATHY 2 0.0009
187 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
188 RESPIRATORY RATE INCREASED 8 0.0009
189 NEPHRITIS 3 0.0009
190 ESSENTIAL TREMOR 1 0.0009
191 DISLOCATION OF VERTEBRA 2 0.0009
192 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
193 ALLODYNIA 1 0.0009
194 BRONCHOSPASM 12 0.0008
195 LIP SWELLING 28 0.0008
196 OXYGEN CONSUMPTION INCREASED 2 0.0008
197 C-REACTIVE PROTEIN INCREASED 30 0.0008
198 END STAGE RENAL DISEASE 15 0.0008
199 BREATH ODOUR 2 0.0008
200 INFUSION SITE WARMTH 1 0.0008
201 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
202 NEURODERMATITIS 3 0.0008
203 BLOOD CALCIUM DECREASED 9 0.0008
204 PEMPHIGUS 10 0.0008
205 CATHETER SITE HAEMORRHAGE 2 0.0008
206 APPLICATION SITE SCAR 1 0.0008
207 CHRONIC SINUSITIS 3 0.0008
208 PEMPHIGOID 6 0.0008
209 APPLICATION SITE WARMTH 1 0.0008
210 LUPUS-LIKE SYNDROME 7 0.0008
211 RHINOVIRUS INFECTION 3 0.0008
212 SPINAL CORD COMPRESSION 3 0.0008
213 ORAL INFECTION 3 0.0008
214 MULTIPLE ALLERGIES 6 0.0008
215 HAND DEFORMITY 10 0.0008
216 LUNG OPACITY 2 0.0008
217 WALKING AID USER 5 0.0008
218 HALLUCINATION, VISUAL 16 0.0008
219 GASTROENTERITIS NOROVIRUS 1 0.0008
220 HIRSUTISM 1 0.0008
221 AREFLEXIA 2 0.0007
222 ANION GAP INCREASED 1 0.0007
223 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
224 INFUSION RELATED REACTION 49 0.0007
225 CLUSTER HEADACHE 1 0.0007
226 APPLICATION SITE INFLAMMATION 1 0.0007
227 DISCHARGE 1 0.0007
228 SYNOVITIS 13 0.0007
229 INCISIONAL HERNIA 1 0.0007
230 H1N1 INFLUENZA 1 0.0007
231 INTENSIVE CARE 1 0.0007
232 HYPERTONIC BLADDER 2 0.0007
233 PULMONARY PAIN 2 0.0007
234 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
235 PULMONARY FIBROSIS 13 0.0007
236 METABOLIC ENCEPHALOPATHY 2 0.0007
237 EPICONDYLITIS 1 0.0007
238 PERICARDITIS 11 0.0007
239 TYPE 2 DIABETES MELLITUS 22 0.0007
240 DAYDREAMING 1 0.0006
241 PRE-EXISTING CONDITION IMPROVED 4 0.0006
242 BLOOD BLISTER 2 0.0006
243 RESPIRATORY RATE DECREASED 2 0.0006
244 FUNGAEMIA 1 0.0006
245 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
246 FOOT DEFORMITY 7 0.0006
247 PNEUMONIA VIRAL 2 0.0006
248 RASH VESICULAR 3 0.0006
249 HYPOVENTILATION 2 0.0006
250 CRYPTOCOCCOSIS 1 0.0006
251 OSTEOARTHRITIS 26 0.0006
252 COELIAC DISEASE 6 0.0006
253 LIVER INJURY 15 0.0006
254 BLOOD CALCIUM ABNORMAL 1 0.0006
255 BLOOD CHOLESTEROL INCREASED 28 0.0006
256 ERYSIPELAS 3 0.0006
257 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
258 HAEMATOMA 15 0.0006
259 INFUSION SITE DISCHARGE 1 0.0006
260 BRONCHIOLITIS 2 0.0006
261 APPLICATION SITE DISCOMFORT 1 0.0006
262 PRESCRIBED UNDERDOSE 11 0.0006
263 HYPERSEXUALITY 1 0.0005
264 ESSENTIAL HYPERTENSION 1 0.0005
265 CONDUCTION DISORDER 1 0.0005
266 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
267 TENDON INJURY 2 0.0005
268 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
269 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
270 JAUNDICE NEONATAL 1 0.0005
271 HYPERCOAGULATION 1 0.0005
272 ARTERIAL DISORDER 1 0.0005
273 LOWER LIMB FRACTURE 10 0.0005
274 HEPATIC MASS 1 0.0005
275 FOOD ALLERGY 4 0.0005
276 EARLY SATIETY 1 0.0005
277 APNOEA 4 0.0005
278 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
279 HYPOTHERMIA 5 0.0005
280 DECUBITUS ULCER 4 0.0005
281 COMPULSIVE SHOPPING 1 0.0005
282 SPINAL STENOSIS 2 0.0005
283 INJURY 34 0.0005
284 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
285 CHEST INJURY 1 0.0005
286 MULTIPLE INJURIES 3 0.0005
287 ABSCESS LIMB 2 0.0005
288 HYPERPHOSPHATAEMIA 1 0.0005
289 INFUSION SITE BRUISING 1 0.0005
290 APPLICATION SITE SCAB 1 0.0005
291 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
292 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
293 TUMOUR LYSIS SYNDROME 4 0.0005
294 ENDOMETRIAL CANCER 1 0.0005
295 GRIP STRENGTH DECREASED 4 0.0005
296 CLOSTRIDIUM TEST POSITIVE 1 0.0005
297 FAECES PALE 1 0.0004
298 SINUSITIS 46 0.0004
299 POST-TRAUMATIC STRESS DISORDER 3 0.0004
300 GLOSSODYNIA 10 0.0004
301 APPLICATION SITE URTICARIA 1 0.0004
302 DISTRIBUTIVE SHOCK 1 0.0004
303 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
304 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
305 ECCHYMOSIS 3 0.0004
306 DYSURIA 16 0.0004
307 CHRONIC KIDNEY DISEASE 33 0.0004
308 EYELID DISORDER 1 0.0004
309 APHTHOUS STOMATITIS 1 0.0004
310 PERSONALITY CHANGE 4 0.0004
311 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
312 WOUND 12 0.0004
313 NEPHROPATHY 4 0.0004
314 INFECTION 62 0.0004
315 NASAL CONGESTION 25 0.0004
316 VAGINAL INFECTION 2 0.0004
317 PHOTOSENSITIVITY REACTION 7 0.0004
318 SKIN ABRASION 2 0.0004
319 ATELECTASIS 4 0.0004
320 SEPTIC SHOCK 18 0.0004
321 BURSITIS 5 0.0004
322 HEPATIC ENZYME INCREASED 28 0.0004
323 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
324 PHARYNGEAL SWELLING 4 0.0004
325 HYPONATRAEMIA 23 0.0004
326 EYE OEDEMA 1 0.0004
327 PSYCHIATRIC SYMPTOM 3 0.0004
328 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
329 RASH MACULO-PAPULAR 9 0.0004
330 DRUG INTOLERANCE 39 0.0004
331 IMMUNODEFICIENCY 6 0.0004
332 HYPERNATRAEMIA 2 0.0004
333 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
334 ENDODONTIC PROCEDURE 1 0.0004
335 DRUG ADMINISTRATION ERROR 12 0.0004
336 MUSCLE TWITCHING 9 0.0004
337 FAILURE TO THRIVE 2 0.0004
338 NERVOUSNESS 20 0.0004
339 PARTIAL SEIZURES 2 0.0004
340 EXFOLIATIVE RASH 1 0.0004
341 EAR INFECTION 10 0.0004
342 ANIMAL BITE 1 0.0004
343 BLISTER 21 0.0004
344 ABDOMINAL MASS 1 0.0004
345 COMPRESSION FRACTURE 2 0.0004
346 HEPATIC CIRRHOSIS 7 0.0004
347 OVERWEIGHT 2 0.0004
348 LOCALISED INFECTION 9 0.0004
349 ANAL ABSCESS 2 0.0004
350 GINGIVITIS 2 0.0004
351 GAMBLING DISORDER 1 0.0004
352 CHONDROPATHY 1 0.0004
353 HYDROCEPHALUS 2 0.0004
354 WOUND INFECTION 4 0.0004
355 SPINAL COMPRESSION FRACTURE 3 0.0004
356 ENDOTRACHEAL INTUBATION 1 0.0004
357 THERAPY NON-RESPONDER 16 0.0004
358 SEASONAL ALLERGY 5 0.0004
359 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
360 PERONEAL NERVE PALSY 2 0.0004
361 TREATMENT FAILURE 29 0.0003
362 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
363 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
364 STRESS CARDIOMYOPATHY 2 0.0003
365 SEDATION 9 0.0003
366 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
367 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
368 SPINAL OSTEOARTHRITIS 3 0.0003
369 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
370 SINUS HEADACHE 2 0.0003
371 OROPHARYNGEAL PAIN 31 0.0003
372 INFUSION SITE REACTION 1 0.0003
373 HYPOAESTHESIA 50 0.0003
374 BONE MARROW DISORDER 1 0.0003
375 CRANIOCEREBRAL INJURY 1 0.0003
376 EMERGENCY CARE 1 0.0003
377 EMBOLISM VENOUS 1 0.0003
378 NOCTURIA 4 0.0003
379 KERATITIS 1 0.0003
380 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
381 CHEST X-RAY ABNORMAL 1 0.0003
382 RHINORRHOEA 21 0.0003
383 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
384 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
385 URTICARIA 54 0.0003
386 NASAL DRYNESS 2 0.0003
387 DERMATITIS ALLERGIC 4 0.0003
388 APPLICATION SITE PAIN 7 0.0003
389 BLEPHAROSPASM 2 0.0003
390 FOREIGN BODY IN THROAT 1 0.0003
391 INFUSION SITE PRURITUS 1 0.0003
392 DRUG EFFECT INCREASED 1 0.0003
393 SEROTONIN SYNDROME 6 0.0003
394 CONTUSION 30 0.0003
395 BREAST CANCER STAGE III 2 0.0003
396 HYPERSENSITIVITY 57 0.0003
397 SINUS DISORDER 6 0.0003
398 FEBRILE NEUTROPENIA 20 0.0003
399 ANXIETY DISORDER 1 0.0003
400 BLOOD POTASSIUM DECREASED 9 0.0003
401 GAIT INABILITY 10 0.0003
402 CYTOKINE RELEASE SYNDROME 6 0.0003
403 COLITIS ISCHAEMIC 2 0.0003
404 DRY MOUTH 24 0.0003
405 PSORIATIC ARTHROPATHY 12 0.0003
406 DRY THROAT 3 0.0003
407 HEPATIC CYST 1 0.0003
408 ABNORMAL LOSS OF WEIGHT 2 0.0003
409 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
410 HYPERTENSION 62 0.0003
411 MOBILITY DECREASED 21 0.0003
412 ASTHMA 33 0.0003
413 HEPATIC FIBROSIS 1 0.0003
414 BLOOD CREATININE ABNORMAL 1 0.0003
415 GRANULOMA 1 0.0003
416 HYPERTRANSAMINASAEMIA 2 0.0003
417 ACUTE KIDNEY INJURY 44 0.0003
418 FORMICATION 2 0.0003
419 RIGHT VENTRICULAR FAILURE 2 0.0003
420 EAR PRURITUS 1 0.0003
421 EMBOLIC STROKE 1 0.0003
422 INCONTINENCE 3 0.0003
423 DUODENAL ULCER 2 0.0003
424 GLOSSITIS 1 0.0003
425 RETINAL HAEMORRHAGE 2 0.0003
426 RECTAL HAEMORRHAGE 12 0.0003
427 NIGHT SWEATS 9 0.0003
428 LEUKOCYTOSIS 5 0.0003
429 DENTAL CARIES 3 0.0003
430 HYPOPHOSPHATAEMIA 2 0.0003
431 INFLUENZA 30 0.0003
432 HYPERACUSIS 1 0.0003
433 SWELLING 25 0.0003
434 GASTRITIS 7 0.0003
435 NASOPHARYNGITIS 49 0.0003
436 HYPOCALCAEMIA 5 0.0003
437 FRACTURE 5 0.0003
438 SCAB 3 0.0003
439 TROPONIN INCREASED 2 0.0003
440 ILLNESS 27 0.0003
441 MIGRAINE 25 0.0003
442 INSURANCE ISSUE 4 0.0003
443 SKIN DISCOLOURATION 12 0.0003
444 CLAVICLE FRACTURE 1 0.0003
445 HYPOKALAEMIA 12 0.0003
446 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
447 FEMUR FRACTURE 8 0.0003
448 ERYTHEMA 53 0.0003
449 DISABILITY 5 0.0003
450 BACTERAEMIA 3 0.0003
451 ATAXIA 3 0.0003
452 PREGNANCY 5 0.0002
453 ADVERSE EVENT 23 0.0002
454 OXYGEN SATURATION DECREASED 14 0.0002
455 MYASTHENIA GRAVIS 2 0.0002
456 FEEDING DISORDER 5 0.0002
457 APPLICATION SITE DISCOLOURATION 1 0.0002
458 LUNG DISORDER 12 0.0002
459 ARTHRITIS BACTERIAL 1 0.0002
460 HYPERURICAEMIA 1 0.0002
461 OSTEOPOROSIS 10 0.0002
462 RENAL FAILURE 32 0.0002
463 CONGESTIVE CARDIOMYOPATHY 1 0.0002
464 ROAD TRAFFIC ACCIDENT 10 0.0002
465 COUGH 67 0.0002
466 CHILLS 28 0.0002
467 HAEMODIALYSIS 2 0.0002
468 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
469 ACUTE MYOCARDIAL INFARCTION 7 0.0002
470 SENSATION OF FOREIGN BODY 2 0.0002
471 INTERVERTEBRAL DISC DISORDER 1 0.0002
472 ALCOHOLISM 1 0.0002
473 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
474 PSEUDOMONAS INFECTION 2 0.0002
475 LIVER FUNCTION TEST INCREASED 5 0.0002
476 INFUSION SITE PAIN 3 0.0002
477 ORTHOSTATIC HYPOTENSION 4 0.0002
478 VERTIGO 14 0.0002
479 MUSCULOSKELETAL PAIN 12 0.0002
480 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
481 BLOOD CREATINE INCREASED 1 0.0002
482 DRUG ERUPTION 4 0.0002
483 STEVENS-JOHNSON SYNDROME 5 0.0002
484 BACK PAIN 52 0.0002
485 JAUNDICE 6 0.0002
486 OEDEMA 12 0.0002
487 UVEITIS 3 0.0002
488 OSTEOMYELITIS 4 0.0002
489 DRUG EFFECT DELAYED 1 0.0002
490 EAR DISORDER 1 0.0002
491 INJECTION SITE REACTION 15 0.0002
492 ISCHAEMIA 1 0.0002
493 NERVE COMPRESSION 2 0.0002
494 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
495 ARTHROPATHY 12 0.0002
496 BREAST CANCER STAGE I 2 0.0002
497 HYPOMAGNESAEMIA 3 0.0002
498 DECREASED APPETITE 50 0.0002
499 FEELING OF DESPAIR 1 0.0002
500 LACERATION 2 0.0002
501 ARTERIOSCLEROSIS 2 0.0002
502 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
503 PROTEINURIA 4 0.0002
504 GESTATIONAL DIABETES 1 0.0002
505 HYPOVOLAEMIC SHOCK 1 0.0002
506 GASTROINTESTINAL TOXICITY 1 0.0002
507 SINUS BRADYCARDIA 2 0.0002
508 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
509 FINGER DEFORMITY 1 0.0002
510 LIVER FUNCTION TEST ABNORMAL 6 0.0002
511 MYALGIA 35 0.0002
512 EAR PAIN 4 0.0002
513 HAEMORRHOIDS 4 0.0002
514 HAEMATURIA 7 0.0002
515 HYPOTENSION 41 0.0002
516 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
517 BODY TEMPERATURE DECREASED 2 0.0002
518 PRURITUS 78 0.0002
519 HYPERVOLAEMIA 1 0.0002
520 DIABETIC NEUROPATHY 1 0.0002
521 ABDOMINAL TENDERNESS 1 0.0002
522 APPLICATION SITE SWELLING 1 0.0002
523 INJECTION SITE BRUISING 16 0.0002
524 ADVERSE DRUG REACTION 18 0.0002
525 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
526 OSTEOPENIA 3 0.0002
527 ABDOMINAL DISCOMFORT 33 0.0002
528 ENDOCARDITIS 1 0.0002
529 INCREASED UPPER AIRWAY SECRETION 1 0.0002
530 EJECTION FRACTION DECREASED 3 0.0002
531 VENTRICULAR EXTRASYSTOLES 2 0.0002
532 THERAPY PARTIAL RESPONDER 3 0.0002
533 PULMONARY HYPERTENSION 4 0.0002
534 TENDERNESS 2 0.0002
535 TRANSFUSION 2 0.0002
536 BLOOD LACTIC ACID INCREASED 1 0.0002
537 OBESITY 3 0.0002
538 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
539 FOOD POISONING 1 0.0002
540 BEHAVIOUR DISORDER 1 0.0002
541 RASH PRURITIC 10 0.0002
542 SWELLING FACE 12 0.0002
543 SLEEP DISORDER 13 0.0002
544 SKIN LACERATION 2 0.0002
545 PULMONARY THROMBOSIS 2 0.0002
546 GASTROINTESTINAL PAIN 2 0.0002
547 MENTAL STATUS CHANGES 5 0.0002
548 FUNGAL INFECTION 6 0.0002
549 NERVE INJURY 2 0.0002
550 CELLULITIS 9 0.0002
551 FACE OEDEMA 3 0.0002
552 CHROMATURIA 4 0.0002
553 CIRCULATORY COLLAPSE 3 0.0002
554 GENERALISED ERYTHEMA 1 0.0002
555 SCAR 3 0.0002
556 MICTURITION URGENCY 2 0.0002
557 JOINT SWELLING 21 0.0002
558 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
559 HALLUCINATION 13 0.0002
560 MUSCULOSKELETAL STIFFNESS 15 0.0002
561 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
562 WHEEZING 10 0.0002
563 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
564 THIRST 3 0.0002
565 ACCIDENT 2 0.0002
566 HYPERLIPIDAEMIA 2 0.0002
567 MUSCULAR WEAKNESS 19 0.0002
568 CONFUSIONAL STATE 27 0.0002
569 STOMATITIS 10 0.0002
570 NEURALGIA 4 0.0002
571 INGUINAL HERNIA 1 0.0002
572 DISCOMFORT 10 0.0002
573 CYTOPENIA 2 0.0002
574 CARDIOMEGALY 2 0.0002
575 CONJUNCTIVITIS 3 0.0002
576 APPLICATION SITE IRRITATION 2 0.0002
577 PNEUMONIA ASPIRATION 4 0.0002
578 DRUG-INDUCED LIVER INJURY 5 0.0002
579 INFUSION SITE SWELLING 1 0.0002
580 BRAIN OEDEMA 2 0.0002
581 FOOT FRACTURE 3 0.0002
582 ANGIOEDEMA 7 0.0002
583 ALOPECIA 31 0.0002
584 DRUG INTERACTION 25 0.0002
585 SLEEP APNOEA SYNDROME 3 0.0002
586 FOREIGN BODY SENSATION IN EYES 1 0.0002
587 CHEST PAIN 29 0.0002
588 ENTERITIS 1 0.0002
589 ACUTE RESPIRATORY FAILURE 3 0.0002
590 HAEMOGLOBIN ABNORMAL 1 0.0002
591 INFLAMMATION 8 0.0002
592 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
593 INCOHERENT 1 0.0002
594 PNEUMONIA 50 0.0002
595 HERPES SIMPLEX 1 0.0002
596 APPLICATION SITE ERYTHEMA 4 0.0002
597 DYSPEPSIA 15 0.0002
598 SEPSIS 17 0.0002
599 SARS-COV-2 TEST POSITIVE 2 0.0002
600 DISORIENTATION 6 0.0002
601 CONDITION AGGRAVATED 46 0.0002
602 DYSPNOEA 85 0.0002
603 RHEUMATOID ARTHRITIS 17 0.0001
604 ILL-DEFINED DISORDER 9 0.0001
605 SINUS CONGESTION 2 0.0001
606 TASTE DISORDER 3 0.0001
607 LIMB INJURY 4 0.0001
608 DISEASE RECURRENCE 7 0.0001
609 TACHYPNOEA 2 0.0001
610 IMPAIRED GASTRIC EMPTYING 2 0.0001
611 RASH ERYTHEMATOUS 7 0.0001
612 RIB FRACTURE 3 0.0001
613 ANAPHYLACTIC REACTION 8 0.0001
614 DROOLING 1 0.0001
615 TOOTH LOSS 3 0.0001
616 HUNGER 2 0.0001
617 APPLICATION SITE REACTION 1 0.0001
618 SKIN REACTION 2 0.0001
619 DIALYSIS 2 0.0001
620 SINUS TACHYCARDIA 2 0.0001
621 RETCHING 3 0.0001
622 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
623 IMPAIRED QUALITY OF LIFE 2 0.0001
624 GRAFT VERSUS HOST DISEASE 1 0.0001
625 INSOMNIA 37 0.0001
626 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
627 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
628 DIZZINESS 68 0.0001
629 ANAEMIA 26 0.0001
630 MELAENA 3 0.0001
631 LIVER DISORDER 6 0.0001
632 BRONCHITIS 10 0.0001
633 URINARY INCONTINENCE 4 0.0001
634 HEPATOTOXICITY 3 0.0001
635 RENAL INJURY 4 0.0001
636 PULMONARY MASS 2 0.0001
637 ORAL PAIN 3 0.0001
638 THROAT IRRITATION 6 0.0001
639 HYDRONEPHROSIS 1 0.0001
640 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
641 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
642 DYSPNOEA EXERTIONAL 5 0.0001
643 ECONOMIC PROBLEM 2 0.0001
644 THERAPEUTIC RESPONSE DECREASED 8 0.0001
645 COLITIS 5 0.0001
646 PAIN 81 0.0001
647 OEDEMA PERIPHERAL 16 0.0001
648 HEART RATE INCREASED 13 0.0001
649 TENDONITIS 2 0.0001
650 HYPOALBUMINAEMIA 1 0.0001
651 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
652 SWOLLEN TONGUE 4 0.0001
653 BRAIN FOG 2 0.0001
654 BALANCE DISORDER 11 0.0001
655 HEAD INJURY 4 0.0001
656 FURUNCLE 1 0.0001
657 PNEUMOTHORAX 2 0.0001
658 BLOOD ALBUMIN DECREASED 1 0.0001
659 PRODUCTIVE COUGH 6 0.0001
660 BLOOD DISORDER 1 0.0001
661 HIP FRACTURE 4 0.0001
662 VISION BLURRED 17 0.0001
663 TACHYCARDIA 11 0.0001
664 RESPIRATORY FAILURE 9 0.0001
665 BLOOD POTASSIUM INCREASED 2 0.0001
666 BACK DISORDER 2 0.0001
667 GASTROINTESTINAL DISORDER 11 0.0001
668 ARTHRALGIA 51 0.0001
669 OFF LABEL USE 107 0.0001
670 HICCUPS 1 0.0001
671 VISUAL IMPAIRMENT 15 0.0001
672 EMBOLISM 1 0.0001
673 HEMIPLEGIA 1 0.0001
674 COAGULOPATHY 2 0.0001
675 POLLAKIURIA 5 0.0001
676 BLOOD UREA INCREASED 2 0.0001
677 ATRIAL SEPTAL DEFECT 1 0.0001
678 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
679 INFUSION SITE ERYTHEMA 1 0.0001
680 HEADACHE 74 0.0001
681 FLUID RETENTION 6 0.0001
682 HYPOPHAGIA 3 0.0001
683 PRODUCT USE ISSUE 22 0.0001
684 PERIPHERAL SWELLING 18 0.0001
685 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
686 MUSCULOSKELETAL DISCOMFORT 2 0.0001
687 NEUROPATHY PERIPHERAL 11 0.0001
688 DELIRIUM 4 0.0001
689 VAGINAL HAEMORRHAGE 5 0.0001
690 RASH MACULAR 4 0.0001
691 ANHEDONIA 3 0.0001
692 HYPERKALAEMIA 4 0.0001
693 AMENORRHOEA 2 0.0001
694 BLOOD CALCIUM INCREASED 1 0.0001
695 HYPOXIA 4 0.0001
696 LYMPHOCYTE COUNT DECREASED 2 0.0001
697 RASH 49 0.0001
698 GASTROINTESTINAL INFECTION 1 0.0001
699 PALLOR 3 0.0001
700 PELVIC PAIN 2 0.0001
701 HYPERGLYCAEMIA 4 0.0001
702 BONE DISORDER 2 0.0001
703 FATIGUE 85 0.0001
704 NEPHROLITHIASIS 5 0.0001
705 RESPIRATORY DISTRESS 3 0.0001
706 IRON DEFICIENCY ANAEMIA 1 0.0001
707 GRAND MAL CONVULSION 1 0.0001
708 COVID-19 19 0.0001
709 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
710 NECK PAIN 6 0.0001
711 BACTERIAL INFECTION 2 0.0001
712 DEFORMITY 1 0.0001
713 PYREXIA 37 0.0001
714 SKIN EXFOLIATION 9 0.0001
715 COMA 5 0.0001
716 ANGINA PECTORIS 3 0.0001
717 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
718 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
719 HERNIA 2 0.0001
720 ARTHRITIS 8 0.0001
721 HOSPICE CARE 1 0.0001
722 HAEMATOCRIT DECREASED 2 0.0001
723 HYPOTONIA 1 0.0001
724 URINARY TRACT INFECTION 17 0.0001
725 SOMNOLENCE 20 0.0001
726 THROMBOCYTOPENIA 11 0.0001
727 BLINDNESS 4 0.0001
728 EUPHORIC MOOD 1 0.0001
729 EAR DISCOMFORT 1 0.0001
730 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
731 PERITONITIS 2 0.0001
732 HYPERBILIRUBINAEMIA 1 0.0001
733 EXPOSURE DURING PREGNANCY 6 0.0001
734 FALL 32 0.0001
735 AGITATION 7 0.0001
736 RENAL IMPAIRMENT 8 0.0001
737 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
738 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
739 EATING DISORDER 2 0.0001
740 BREAST PAIN 1 0.0001
741 JOINT INJURY 2 0.0001
742 ATRIAL FIBRILLATION 9 0.0001
743 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
744 BIPOLAR DISORDER 1 0.0001
745 BACK INJURY 1 0.0001
746 BLOOD CREATININE INCREASED 6 0.0001
747 ASPIRATION 1 0.0001
748 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
749 SYNCOPE 9 0.0001
750 TRANSAMINASES INCREASED 2 0.0001
751 TOOTH DISORDER 2 0.0001
752 DIARRHOEA 58 0.0001
753 PULMONARY OEDEMA 4 0.0001
754 RASH PAPULAR 2 0.0001
755 SNEEZING 2 0.0001
756 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
757 FISTULA 1 0.0001
758 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
759 EYE INFECTION 1 0.0001
760 PAIN IN EXTREMITY 26 0.0001
761 IMPAIRED DRIVING ABILITY 1 0.0001
762 CHOLECYSTECTOMY 1 0.0001
763 INTERNAL HAEMORRHAGE 1 0.0001
764 ELECTROLYTE IMBALANCE 1 0.0001
765 ABDOMINAL PAIN 20 0.0001
766 BURNING SENSATION 6 0.0001
767 PALPITATIONS 10 0.0001
768 COVID-19 PNEUMONIA 1 0.0001
769 PLATELET COUNT DECREASED 9 0.0001
770 BLOOD IRON DECREASED 1 0.0001
771 BLOOD PRESSURE FLUCTUATION 2 0.0001
772 RESTLESSNESS 3 0.0001
773 ENCEPHALOPATHY 2 0.0001
774 HYPERCALCAEMIA 1 0.0001
775 OSTEONECROSIS OF JAW 2 0.0001
776 ANXIETY 23 0.0001
777 GENERALISED OEDEMA 1 0.0001
778 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
779 ILEUS 1 0.0001
780 INTENTIONAL PRODUCT MISUSE 7 0.0001
781 AGGRESSION 4 0.0001
782 ASTHENIA 30 0.0001
783 HOT FLUSH 6 0.0001
784 INTESTINAL OBSTRUCTION 3 0.0001
785 ABDOMINAL PAIN LOWER 2 0.0001
786 HAEMATEMESIS 2 0.0001
787 FLUSHING 8 0.0001
788 HEPATITIS 2 0.0001
789 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
790 ABDOMINAL PAIN UPPER 16 0.0001
791 HIATUS HERNIA 1 0.0001
792 DIPLOPIA 2 0.0001
793 VOMITING 36 0.0001
794 SUICIDAL IDEATION 7 0.0001
795 MUCOSAL INFLAMMATION 2 0.0001
796 ADVERSE REACTION 1 0.0001
797 DEHYDRATION 10 0.0001
798 NEOPLASM MALIGNANT 5 0.0001
799 DEPRESSION 17 0.0001
800 BLOOD BILIRUBIN INCREASED 2 0.0001
801 DEVICE MECHANICAL ISSUE 1 0.0001
802 CORONARY ARTERY OCCLUSION 1 0.0001
803 MEMORY IMPAIRMENT 10 0.0001
804 APPLICATION SITE RASH 1 0.0001
805 PROCEDURAL PAIN 2 0.0001
806 MEDICATION ERROR 4 0.0001
807 BLOOD PRESSURE INCREASED 11 0.0001
808 CARDIO-RESPIRATORY ARREST 3 0.0001
809 HAEMOPTYSIS 2 0.0001
810 COORDINATION ABNORMAL 1 0.0001
811 APHONIA 1 0.0001
812 CARPAL TUNNEL SYNDROME 1 0.0001
813 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
814 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
815 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
816 PAIN IN JAW 2 0.0001
817 LOSS OF CONSCIOUSNESS 9 0.0001
818 INTENTIONAL DOSE OMISSION 2 0.0001
819 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
820 SKIN BURNING SENSATION 5 0.0001
821 HYPERSOMNIA 2 0.0001
822 CONSTIPATION 15 0.0001
823 APATHY 1 0.0001
824 GASTROENTERITIS 1 0.0001
825 DYSPHONIA 4 0.0001
826 SURGERY 4 0.0001
827 ASCITES 2 0.0001
828 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
829 ABDOMINAL DISTENSION 7 0.0001
830 RESPIRATORY DISORDER 2 0.0001
831 IRRITABILITY 4 0.0001
832 HYPOAESTHESIA ORAL 1 0.0001
833 LACRIMATION INCREASED 2 0.0001
834 CORONARY ARTERY DISEASE 2 0.0001
835 DRUG INEFFECTIVE 87 0.0001
836 PLEURAL EFFUSION 4 0.0001
837 SKIN IRRITATION 3 0.0001
838 EPILEPSY 2 0.0001
839 FEELING HOT 4 0.0001
840 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
841 DEVICE RELATED INFECTION 1 0.0001
842 LIMB DISCOMFORT 2 0.0001
843 ANKLE FRACTURE 1 0.0001
844 BONE DENSITY DECREASED 2 0.0001
845 MOOD SWINGS 2 0.0001
846 ABSCESS 1 0.0001
847 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
848 CARDIAC FAILURE 5 0.0001
849 HYPOGLYCAEMIA 3 0.0001
850 CHOLELITHIASIS 2 0.0001
851 NO ADVERSE EVENT 11 0.0001
852 CARDIAC ARREST 5 0.0001
853 EXPIRED PRODUCT ADMINISTERED 2 0.0001
854 DRY EYE 3 0.0001
855 LEUKOPENIA 3 0.0001
856 MUSCLE SPASMS 11 0.0001
857 URINARY RETENTION 2 0.0001
858 NAUSEA 47 0.0001
859 CHEST DISCOMFORT 6 0.0001
860 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
861 EMOTIONAL DISTRESS 7 0.0001
862 NIGHTMARE 2 0.0001
863 SPEECH DISORDER 3 0.0001
864 EOSINOPHILIA 1 0.0001
865 DERMATITIS ATOPIC 3 0.0001
866 DEPRESSED MOOD 3 0.0001
867 COLD SWEAT 1 0.0001
868 BRADYCARDIA 3 0.0001
869 HEAD DISCOMFORT 1 0.0001
870 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
871 GALLBLADDER DISORDER 1 0.0001
872 PRODUCT ADHESION ISSUE 2 0.0001
873 GOUT 1 0.0001
874 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
875 TREATMENT NONCOMPLIANCE 3 0.0001
876 UNDERDOSE 4 0.0001
877 ACCIDENTAL OVERDOSE 2 0.0001
878 HYPERHIDROSIS 7 0.0001
879 TREMOR 9 0.0001
880 BLOOD GLUCOSE ABNORMAL 1 0.0001
881 WEIGHT DECREASED 15 0.0001
882 HEPATIC STEATOSIS 1 0.0001
883 PSORIASIS 7 0.0001
884 EPISTAXIS 4 0.0001
885 FLATULENCE 3 0.0001
886 BLOOD URINE PRESENT 1 0.0001
887 MALAISE 23 0.0001
888 GAIT DISTURBANCE 10 0.0001
889 CHOLESTASIS 1 0.0001
890 DRUG PRESCRIBING ERROR 1 0.0001
891 ERUCTATION 1 0.0001
892 PRODUCT QUALITY ISSUE 7 0.0001
893 CHOKING 1 0.0001
894 BONE PAIN 3 0.0001
895 CATARACT 3 0.0001
896 BLOOD PRESSURE ABNORMAL 1 0.0001
897 CARDIAC FAILURE CONGESTIVE 4 0.0000
898 FULL BLOOD COUNT DECREASED 1 0.0000
899 DYSKINESIA 2 0.0000
900 HAEMOGLOBIN DECREASED 5 0.0000
901 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
902 RHABDOMYOLYSIS 2 0.0000
903 INTENTIONAL DRUG MISUSE 1 0.0000
904 RENAL FAILURE ACUTE 2 0.0000
905 IMPAIRED WORK ABILITY 1 0.0000
906 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
907 FAECES DISCOLOURED 1 0.0000
908 AMNESIA 3 0.0000
909 DEVICE DISLOCATION 2 0.0000
910 FEELING ABNORMAL 11 0.0000
911 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
912 HOSPITALISATION 7 0.0000
913 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
914 WEIGHT INCREASED 10 0.0000
915 PARAESTHESIA 7 0.0000
916 HEART RATE IRREGULAR 1 0.0000
917 NEUTROPENIA 6 0.0000
918 APPLICATION SITE PRURITUS 1 0.0000
919 INCORRECT DOSE ADMINISTERED 10 0.0000
920 TINNITUS 2 0.0000
921 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
922 DYSPHAGIA 4 0.0000
923 BLOOD GLUCOSE DECREASED 2 0.0000
924 DIABETIC KETOACIDOSIS 1 0.0000
925 ABASIA 1 0.0000
926 DYSGEUSIA 3 0.0000
927 EXTRAPYRAMIDAL DISORDER 1 0.0000
928 UNEVALUABLE EVENT 3 0.0000
929 DIABETES MELLITUS 3 0.0000
930 ANAPHYLACTIC SHOCK 1 0.0000
931 DEAFNESS 1 0.0000
932 ECZEMA 2 0.0000
933 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
934 PRODUCT DOSE OMISSION ISSUE 11 0.0000
935 DISTURBANCE IN ATTENTION 2 0.0000
936 FREQUENT BOWEL MOVEMENTS 1 0.0000
937 HAEMATOCHEZIA 2 0.0000
938 ABNORMAL DREAMS 1 0.0000
939 DIVERTICULITIS 1 0.0000
940 DRUG ABUSE 3 0.0000
941 FEELING COLD 1 0.0000
942 PANCYTOPENIA 2 0.0000
943 DEMENTIA 1 0.0000
944 CONVULSION 2 0.0000
945 DEATH 30 0.0000
946 HERPES ZOSTER 2 0.0000
947 PRODUCT SUBSTITUTION ISSUE 2 0.0000
948 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
949 HEPATIC FAILURE 1 0.0000
950 APHASIA 1 0.0000
951 INJECTION SITE RASH 1 0.0000
952 OVERDOSE 7 0.0000
953 EMOTIONAL DISORDER 1 0.0000
954 CARDIAC DISORDER 3 0.0000
955 PULMONARY EMBOLISM 3 0.0000
956 CYSTITIS 1 0.0000
957 HYPOTHYROIDISM 1 0.0000
958 EYE DISORDER 1 0.0000
959 EYE PRURITUS 1 0.0000
960 TOXICITY TO VARIOUS AGENTS 5 0.0000
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
962 CEREBROVASCULAR ACCIDENT 5 0.0000
963 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
964 HEART RATE DECREASED 1 0.0000
965 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
966 CEREBRAL HAEMORRHAGE 1 0.0000
967 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
968 CRYING 1 0.0000
969 INJECTION SITE MASS 1 0.0000
970 INJECTION SITE SWELLING 2 0.0000
971 SEIZURE 3 0.0000
972 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
973 DRUG DEPENDENCE 4 0.0000
974 THROMBOSIS 2 0.0000
975 INJECTION SITE ERYTHEMA 3 0.0000
976 HYPOACUSIS 1 0.0000
977 MYOCARDIAL INFARCTION 4 0.0000
978 DRY SKIN 3 0.0000
979 COLITIS ULCERATIVE 1 0.0000
980 BREAST CANCER 2 0.0000
981 COGNITIVE DISORDER 1 0.0000
982 ARRHYTHMIA 1 0.0000
983 DRUG EFFECT DECREASED 1 0.0000
984 EYE PAIN 1 0.0000
985 DEVICE EXPULSION 1 0.0000
986 DEEP VEIN THROMBOSIS 1 0.0000
987 BLOOD PRESSURE DECREASED 1 0.0000
988 INJECTION SITE PRURITUS 1 0.0000
989 INJECTION SITE PAIN 4 0.0000
990 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
991 DEVICE ISSUE 1 0.0000
992 BLOOD GLUCOSE INCREASED 2 0.0000
993 DISEASE PROGRESSION 1 0.0000